Rebecca Sunshine
Personalreferent bei COHERUS BIOSCIENCES, INC.
Ursprung des Netzwerks ersten Grades von Rebecca Sunshine
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 49 | |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction
14
| Extinct | Pharmaceuticals: Major | 14 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA.
2
| Extinct | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rebecca Sunshine
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Graduate Degree Masters Business Admin Masters Business Admin | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member Public Communications Contact Chief Tech/Sci/R&D Officer | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Director of Finance/CFO | |
| University of San Francisco | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| University of California, Los Angeles | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| University of California, Davis | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Investor Relations Contact Corporate Officer/Principal Director/Board Member | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HUMANIGEN, INC. | Biotechnology | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Neuvogen, Inc. | Director/Board Member Director/Board Member | ||
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Molecular Devices LLC
 Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| San Jose State University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| Washington State University | College/University | Doctorate Degree Undergraduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member General Counsel | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Chairman Chief Executive Officer | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Parenteral Drug Association | Chairman Corporate Officer/Principal | ||
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Florida | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Boston University | College/University | Masters Business Admin Graduate Degree | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member General Counsel |
Statistik
International
| Vereinigte Staaten | 51 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 16 |
| Commercial Services | 4 |
Operativ
| Director/Board Member | 280 |
| Corporate Officer/Principal | 187 |
| Independent Dir/Board Member | 77 |
| Undergraduate Degree | 57 |
| Chief Tech/Sci/R&D Officer | 50 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Healy | 50 |
| Alan C. Mendelson | 45 |
| Samuel R. Nussbaum | 32 |
| Mark Stolper | 28 |
| Ali Satvat | 28 |
| Laura Brege | 27 |
| Vaughn M. Kailian | 27 |
| Mats Wahlström | 25 |
| V. Lawlis | 21 |
| Graham K. Crooke | 21 |
| S. Torres | 21 |
| Mary Szela | 19 |
| Thomas Hancock | 19 |
| Georgia Erbez | 18 |
| August Troendle | 16 |
- Börse
- Insiders
- Rebecca Sunshine
- Unternehmensverbindungen